Neurocarrus Inc
Targeted pain relief without addiction.
Monterey · Founded 2017 · $354K raised
- Headquarters
- Monterey, California
- Employees
- 1–10
- Founded
- 2017
- Website
- neurocarrus.com
- Total Funding
- $354K
- Last Round
- $344K SAFEApr 2019
- Rounds
- 3
About
Neurocarrus is a pre-clinical biotechnology company developing targeted protein therapeutics for pain management and neurological disorders without addiction risk. Its Apollo drug delivery platform engineers proteins to target and deliver therapeutics directly to selected tissues and cells. Lead assets include N-001 for acute surgical pain, NL-17 for migraine prevention, and N-19a for chronic pain — all designed to provide lasting relief without opioid-associated side effects. The company is backed by NIH SBIR grants and has partnered with Stanford University and the VA Palo Alto Medical Center.
Summary
Neurocarrus Inc is a company based in Monterey, founded in 2017. It has raised $354K in total across 3 rounds, most recently a $344K SAFE round in Apr 2019. Investors include National Institute on Drug Abuse and SOSV.
Tech & App Stack
6 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2019
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.